On the recordMay 19, 2014
I believe that FDA should be given more resources so that they can engage consultants, convene meetings with outside experts and also with patient advocacy groups to a greater extent.
Source
congress.govEditor's note · Context
Advocating for increased FDA resources to improve collaboration with experts and advocacy groups.
Share
More from Eliot Engel
Nov 18, 2020
I once again thank Mr. Jeffries for authoring this important legislation. Mr. Speaker, I urge my colleagues on both sides of the aisle to support this legislation, and I yield back the balance of my time. The SPEAKER pro tempore. The…
Dec 8, 2020
I know Mr. Meeks very well and I know that he will do an excellent job--an excellent job--as chairman.
Dec 3, 2020
I reserve the balance of my time. Mr. McCAUL. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, in closing, I thank my friend and fellow Texan, Representative Conaway, who represents the family, for introducing this…
Dec 8, 2020
Why have there been no designations by us of Russian companies and individuals who are so clearly and shamelessly giving Assad a lifeline?
Other voices in this conversation
